Schizophrenia Trial of Aripiprazole

NCT00237913 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
700
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Otsuka Pharmaceutical Development & Commercialization, Inc.

Collaborators